What are the costs & benefits of the EU’s #UnitaryPatent and Unified Patent Court? Join Domien Op de Beeck in Amste… twitter.com/i/web/status/1…

New Draft Implementing Regulations propose key changes for pharmaceuticals in China. We highlight what these change… twitter.com/i/web/status/1…

Big congratulations to our Life Sciences team who won not one but TWO Impact Case of the Year awards at the LMG Lif… twitter.com/i/web/status/1…

RT @twobirdsIP: To us #WorldIPDay is about recognising the innovation that has been created in this world to make things better. To our cli…

Are you attending the LSX World Congress in London? Join partner James Baillieu where he will be co-hosting the Bio… twitter.com/i/web/status/1…

The return of biosimilar substitution in France - read more in our article on this regulatory update… twitter.com/i/web/status/1…

Find out all you need to know about UK Digital Health Law in the newly published ICLG Guide to Digital Health 2022… twitter.com/i/web/status/1…

France has introduced a new research tax credit that private companies will be eligible for if they agree collabora… twitter.com/i/web/status/1…

On 1 July 2021, the early access and compassionate use reform entered into force in France, concerning early access… twitter.com/i/web/status/1…